Great find Pb. Wonder why this is not on the website?
Agreed - perhaps a tale of 2 platforms - one purchased by Novogen - with 2 very different backgrounds - might just be the answer Stayso...
As you can see lots of investment and not just financial..and Novogen have been privileged to have it and be part of it - but its a complete different environment from where Novogen had been previously for all those years.
Childrens cancers are a whole other field and priorities would be tested quite heavily within Novogen since they purchased this platform and bought Gunning & Stehn on board - I have no doubt.
